Abstract
A lipopolysaccharide (LPS) is considered to be one of the major determinants of virulence expression and infection of virulent Coxiella burnetii. The LPSs from virulent phase I (LPS I) and from avirulent phase II (LPS II) bacteria were investigated for their chemical composition, structure and biological properties. LPS II is of rough (R) type in contrast to LPS I, which is phenotypically smooth (S) and contains a noticeable amount of two sugars virenose (Vir) and dihydrohydroxystreptose (Strep), which have not been found in other LPSs and can be considered as unique biomarkers of the bacterium. Both sugars were suggested to be located mostly in terminal positions of the O-specific chain of LPS I (O-PS I) and to be involved in the immunobiology of Q fever. There is a need to establish a more detailed chemical structure of LPS I in connection with prospective, deeper studies on mechanisms of pathogenesis and immunity of Q fever, its early and reliable diagnosis, and effective prophylaxis against the disease. This will also help to better understanding of host-pathogen interactions and contribute to improved modulation of pathological reactions which in turn are prerequisite for research and development of vaccines of new type. A fundamental understanding of C. burnetii LPS biosynthesis is still lacking. The intracellular nature of the bacterium, lack of genetic tools and its status as a selected agent have made elucidating basic physiological mechanisms challenging. The GDP-β-D-Vir biosynthetic pathway proposed most recently is an important initial step in this endeavour. The current advanced technologies providing the genetic tools necessary to screen C. burnetii mutants and propagate isogenic mutants might speed the discovery process.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander C, Rietschel ET (2001) Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7:167–202
Al-Hendy A, Toivanen P, Skurnik M (1991) Expression cloning of Yersinia enterocolitica O:3 rfb gene cluster in Escherichia coli K12. Microb Pathog 10:47–59
Amano K, Williams JC (1984) Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii. J Bacteriol 160:994–1002
Amano K, Williams JC, Missler SR et al (1987) Structure and biological relationships of Coxiella burnetii lipopolysaccharides. J Biol Chem 262:4740–4747
Aschauer H, Grob A, Hildebrandt J et al (1990) Highly purified lipid X is devoid of immunostimulatory activity. Isolation and characterization of immunostimulating contaminants in a batch of synthetic lipid X. J Biol Chem 265:9159–9164
Awomoyi AA, Rallabhandi P, Pollin TI et al (2007) Association of TLR4 polymorphisms with asymptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 179:3171–3177
Baca OG, Martinez IL, Aragon AS et al (1980) Isolation and partial characterization of a lipopolysaccharide from phase II Coxiella burnetii. Can J Microbiol 26:819–826
Bisercic M, Feutrier JY, Reeves PR (1991) Nucleotide sequences of the gnd genes from nine natural isolates of Escherichia coli: evidence of intragenic recombination as a contributing factor in the evolution of the polymorphic gnd locus. J Bacteriol 173:3894–3900
Bowen RA (2008) Protein hydrophobicity plots. http://www.vivo.colostate.edu/molkit/hydropathy/index.html
Bulut Y, Faure E, Thomas L et al (2002) Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 168:1435–1440
Burns SM, Hull SI (1998) Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. Infect Immun 66:4244–4253
Capo C, Zugun F, Stein A et al (1996) Upregulation of tumor necrosis factor-α and interleukin-1β in Q fever endocarditis. Infect Immun 64:1638–1642
Capo C, Amirayan N, Ghigo E et al (1999) Circulating cytokine balance and activation markers of leucocytes in Q fever. Clin Exp Immunol 115:120–123
Caroff M, Brisson JR, Martin A et al (2000) Structure of the Bordetella pertussis 1414 endotoxin. FEBS Lett 477:8–14
Chen MM, Glover KJ, Imperiali B (2007) From peptide to protein: comparative analysis of the substrate specificity of N-linked glycosylation in Campylobacter jejuni. Biochemistry 46:5579–5585
Clarke BR, Cuthbertson L, Whitfield C (2004) Nonreducing terminal modifications determine the chain length of polymannose O-antigens of Escherichia coli and couple chain termination to polymer export via an ATP-binding cassette transporter. J Biol Chem 279:35709–35718
Coleman SA, Fischer ER, Howe D et al (2004) Temporal analysis of Coxiella burnetii morphological differentiation. J Bacteriol 186:7344–7352
Coleman SA, Fischer ER, Cockrell DC et al (2007) Proteome and antigen profiling of Coxiella burnetii developmental forms. Infect Immun 75:290–298
Darveau RP, Pham TT, Lemley K et al (2004) Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 72:5041–5051
Dellacasagrande J, Capo C, Raoult D et al (1999) IFN-γ-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J Immunol 162:2259–2265
Dellacasagrande J, Ghigo E, Capo C et al (2000a) Coxiella burnetii survives in monocytes from patients with Q fever endocarditis: involvement of tumor necrosis factor. Infect Immun 68:160–164
Dellacasagrande J, Ghigo E, Machergui-El Hammami S et al (2000b) Alpha(v)beta(3) integrin and bacterial lipopolysaccharide are involved in Coxiella burnetii-stimulated production of tumor necrosis factor by human monocytes. Infect Immun 68:5673–5678
Demerec M, Adelberg EA, Clark AJ et al (1966) A proposal for a uniform nomenclature in bacterial genetics. Genetics 54:61–76
Denison AM, Massung RF, Thompson HA (2007) Analysis of the O-antigen biosynthesis regions of phase II isolates of Coxiella burnetii. FEMS Microbiol Lett 267:102–107
Diaz QM, Lukacova M (1998) Immunological consequences of Coxiella burnetii phase variation. Acta Virol 42:181–185
Dotson SB, Rush JS, Ricketts AD et al (1995) Mannosylphosphoryldolichol-mediated O-mannosylation of yeast glycoproteins: stereospecificity and recognition of the alpha-isoprene unit by a purified mannosyltransferase. Arch Biochem Biophys 316:773–779
Doyle SL, O’ Neill LA (2006) Toll-like receptors from the discovery of NF-χB to new insights into transcriptional regulations in innate imunity. Biochem Pharmacol 72:1102–1113
D’Souza-Schorey C, McLachlan KR, Krag SS et al (1994) Mammalian glycosyltransferases prefer glycosyl phosphoryl dolichols rather than glycosyl phosphoryl polyprenols as substrates for oligosaccharyl synthesis. Arch Biochem Biophys 308:497–503
Emmerson JR, Gally DL, Roe AJ (2006) Generation of gene deletions and gene replacements in Escherichia coli O157:H7 using a temperature sensitive allelic exchange system. Biol Proced Online 8:153–162
Erridge C, Bennett-Guerrero E, Poxton IR (2002) Structure and function of lipopolysaccharides. Microbes Infect 4:837–851
Flebbe LM, Chapes SK, Morrison DC (1990) Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. J Immunol 145:505–514
Ftacek P, Skultety L, Toman R (2000) Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide. J Endotoxin Res 6:369–376
Gajdosova E, Kovacova E, Toman R et al (1994) Immunogenicity of Coxiella burnetii whole cells and their outer membrane components. Acta Virol 38:339–344
Girard R, Pedron T, Uematsu S et al (2003) Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via toll-like receptor 2. J Cell Sci 116:293–302
Golenbock DT, Hampton RY, Qureshi N et al (1991) Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 266:19490–19498
Gunn JS, Ernst RK (2007) The structure and function of Francisella lipopolysaccharide. Ann NY Acad Sci 1105:202–218
Hackstadt T (1986) Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates. Infect Immun 52:337–340
Hackstadt T, Peacock MG, Hitchcock PJ et al (1985) Lipopolysaccharide variation in Coxiella burnetii: intrastrain heterogeneity in structure and antigenicity. Infect Immun 48:359–365
Hajjar AM, O’Mahony DS, Ozinsky A et al (2001) Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166:15–19
Heinrichs DE, Whitfield C, Valvano MA (1999) Biosynthesis and genetics of lipopolysaccharide core. In: Brade H, Opal SM, Vogel SN, Morrison DC (eds) Endotoxin in health and disease. Marcel Dekker, New York/Basel, pp 305–330
Heinzen RA, Hackstadt T (1996) A developmental stage-specific histone H1 homolog of Coxiella burnetii. J Bacteriol 178:5049–5052
Helbig JH, Luck PC, Knirel YA et al (1995) Molecular characterization of a virulence-associated epitope on the lipopolysaccharide of Legionella pneumophila serogroup 1. Epidemiol Infect 115:71–78
Hirschfeld M, Weiss JJ, Toshchakov V et al (2001) Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69:1477–1482
Hobbs M, Reeves PR (1994) The JUMPstart sequence: a 39 bp element common to several polysaccharide gene clusters. Mol Microbiol 12:855–856
Hollenstein K, Dawson RJ, Locher KP (2007) Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol 17:412–418
Holst O (1999) Chemical structure of the core region of lipopolysaccharides. In: Brade H, Opal SM, Vogel SN, Morrison DC (eds) Endotoxin in health and disease. Marcel Dekker, New York/Basel, pp 115–154
Honstettre A, Ghigo E, Moynnault A et al (2004) Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through toll-like receptor 4. J Immunol 172:3695–3703
Hoover TA, Culp DW, Vodkin MH et al (2002) Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (Crazy), of the Coxiella burnetii nine mile strain. Infect Immun 70:6726–6733
Hussein A, Kovacova E, Toman R (2001) Isolation and evaluation of Coxiella burnetii O-polysaccharide antigen as immunodiagnostic reagent. Acta Virol 45:173–180
Jimenez de Bagues MP, Gross A, Terraza A et al (2005) Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation. Clin Immunol 114:227–238
Joiner KA (1988) Complement evasion by bacteria and parasites. Ann Rev Microbiol 42:201–230
Kawai T, Akira S (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann NY Acad Sci 1143:1–20
Kean EL, Rush JS, Waechter CJ (1994) Activation of GlcNAc-P-P-dolichol synthesis by mannosylphosphoryldolichol is stereospecific and requires a saturated alpha-isoprene unit. Biochemistry 33:10508–10512
Keenleyside WJ, Whitfield C (1999) Genetics and biosynthesis of lipopolysaccharide O-antigens. In: Brade H, Opal SM, Vogel SN, Morrison DC (eds) Endotoxin in health and disease. Marcel Dekker, New York/Basel, pp 331–358
King JD, Kocincova D, Westman EL et al (2009) Review: lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun 15:261–312
Knirel YA, Rietschel ET, Marre R et al (1994) The structure of the O-specific chain of Legionella pneumophila serogroup 1 lipopolysaccharide. Eur J Biochem 221:239–245
Kubes M, Kuzmova Z, Gajdosova E et al (2006) Induction of tumor necrosis factor alpha in murine macrophages with various strains of Coxiella burnetii and their lipopolysaccharides. Acta Virol 50:93–99
Lien E, Sellati TJ, Yoshimura A et al (1999) Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274:33419–33425
Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487–501
Lorenz E, Mira JP, Cornish KL et al (2000) A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68:6398–6401
Lu YC, Yeh WC, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42:145–151
Luck PC, Freier T, Steudel C et al (2001) Point mutation in the active site of Legionella pneumophila O-acetyltransferase results in modified lipopolysaccharide but does not influence virulence. Int J Med Microbiol 291:345–352
Luneberg E, Zahringer U, Knirel YA et al (1998) Phase-variable expression of lipopolysaccharide contributes to the virulence of Legionella pneumophila. J Exp Med 188:49–60
Luneberg E, Zetzmann N, Alber D et al (2000) Cloning and functional characterization of a 30 kb gene locus required for lipopolysaccharide biosynthesis in Legionella pneumophila. Int J Med Microbiol 290:37–49
Luneberg E, Mayer B, Daryab N et al (2001) Chromosomal insertion and excision of a 30 kb unstable genetic element is responsible for phase variation of lipopolysaccharide and other virulence determinants in Legionella pneumophila. Mol Microbiol 39:1259–1271
Malley R, Hennecke P, Morse SC et al (2003) Recognition of pneumolysin by toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 100:1966–1971
Marrie TJ, Raoult D (1997) Q fever – a review and issues for the next century. J Antimicrob Agents 8:145–161
Mayer H, Radziejewska-Lebrecht J, Schramek S (1988) Chemical and immunochemical studies on lipopolysaccharides of Coxiella burnetii phase I and phase II. Adv Exp Med Biol 228:577–591
McCaul TF, Banerjee-Bhatnagar N, Williams JC (1991) Antigenic differences between Coxiella burnetii cells revealed by postembedding immunoelectron microscopy and immunoblotting. Infect Immun 59:3243–3253
McLachlan KR, Krag SS (1994) Three enzymes involved in oligosaccharide-lipid assembly in Chinese hamster ovary cells differ in lipid substrate preference. J Lipid Res 35:1861–1868
Meghari S, Honstettre A, Lepidi H et al (2005) TLR2 is necessary to inflammatory response in Coxiella burnetii infection. Ann NY Acad Sci 1063:161–166
Moran AP, Zähringer U, Seydel U et al (1991) Structural analysis of the lipid A component of Campylobacter jejuni CCUG 10936 (serotype O:2) lipopolysaccharide. Description of a lipid A containing a hybrid backbone of 2-amino-2-deoxy-D-glucose and 2,3-diamino-2,3-dideoxy-D-glucose. Eur J Biochem 198:459–469
Nagy G, Palkovics T, Otto A et al (2008) “Gently rough”: the vaccine potential of a Salmonella enterica regulatory lipopolysaccharide mutant. J Infect Dis 198:1699–1706
Narasaki CT, Mertens K, Samuel JE (2011) Characterization of the GDP-D-mannose biosynthesis pathway in Coxiella burnetii: the initial steps for GDP-β-D-virenose biosynthesis. PLoS One 6(10):e25514
Nelson K, Selander RK (1994) Intergeneric transfer and recombination of the 6-phosphogluconate dehydrogenase gene (gnd) in enteric bacteria. Proc Natl Acad Sci USA 91:10227–10231
Nesper J, Lauriano CM, Klose KE et al (2001) Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation. Infect Immun 69:435–445
O’Neill LA (2006) How toll-like receptors signal: what we know and what we don’t know. Curr Opin Immunol 18:3–9
Palkovicova K, Ihnatko R, Vadovic P et al (2009) A monoclonal antibody specific for a unique biomarker virenose in a lipopolysaccharide of Coxiella burnetii. Clin Microbiol Infect 15:183–184
Pretat L, Toman R, Vadovic P et al (2009) Intracellular trafficking of the Coxiella burnetii lipopolysaccharide. Clin Microbiol Infect 15:185–187
Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Ann Rev Biochem 71:635–700
Reeves PR, Hobbs M, Valvano MA et al (1996) Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol 4:495–503
Rietschel ET, Brade H, Brade L et al (1987) Lipid A, the endotoxic centre of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog Clin Biol Res 231:25–53
Rietschel ET, Kirikae T, Schade U et al (1993) The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 187:169–190
Rocchetta HL, Burrows LL, Lam JS (1999) Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 63:523–553
Rojas G, Saldias S, Bittner M et al (2001) The rfaH gene, which affects lipopolysaccharide synthesis in Salmonella enterica serovar Typhi, is differentially expressed during the bacterial growth phase. FEMS Microbiol Lett 204:123–128
Rush JS, Shelling JG, Zingg NS et al (1993) Mannosylphosphoryldolichol-mediated reactions in oligosaccharide-P-P-dolichol biosynthesis. Recognition of the saturated alpha-isoprene unit of the mannosyl donor by pig brain mannosyltransferases. J Biol Chem 268:13110–13117
Rush JS, Rick PD, Waechter CJ (1997) Polyisoprenyl phosphate specificity of UDP-GlcNAc: undecaprenyl phosphate N-acetylglucosaminyl 1-P transferase from E.coli. Glycobiology 7:315–322
Rush JS, Alaimo C, Robbiani R et al (2010) A novel epimerase that converts GlcNAc-P-P-undecaprenol to GalNAc-P-P-undecaprenol in Escherichia coli O157. J Biol Chem 285:1671–1680
Samuel G, Reeves P (2003) Biosynthesis of O-antigens: genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly. Carbohydr Res 338:2503–2519
Sandlin RC, Lampel KA, Keasler SP et al (1995) Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect Immun 63:229–237
Sandlin RC, Goldberg MB, Maurelli AT (1996) Effect of O side-chain length and composition on the virulence of Shigella flexneri 2a. Mol Microbiol 22:63–73
Schramek S, Mayer H (1982) Different sugar composition of lipopolysaccharides isolated from phase I and pure phase II cells of Coxiella burnetii. Infect Immun 38:53–57
Schramek S, Radziejewska-Lebrecht J, Mayer H (1985) 3-C-branched aldoses in lipopolysaccharide of phase I Coxiella burnetii and their role as immunodominant factors. Eur J Biochem 148:445–461
Seshadri R, Hendrix LR, Samuel JE (1999) Differential expression of translational elements by life cycle variants of Coxiella burnetii. Infect Immun 67:6026–6033
Seshadri R, Paulsen IT, Eisen JA et al (2003) Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc Natl Acad Sci USA 100:5455–5460
Seydel U, Wiese A, Schromm AB et al (1999) A biophysical view on the function and activity of endotoxins. In: Brade H, Opal SM, Vogel SN, Morrison DC (eds) Endotoxin in health and disease. Marcel Dekker, New York/Basel, pp 195–219
Shannon JG, Howe D, Heinzen RA (2005) Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule. Proc Natl Acad Sci USA 102:8722–8727
Shimazu R, Akashi S, Ogata H et al (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4. J Exp Med 189:1777–1782
Skultety L, Toman R, Patoprsty V (1998) A comparative study of lipopolysaccharides from two Coxiella burnetii strains considered to be associated with acute and chronic Q fever. Carbohydr Polymers 35:189–194
Skultety L, Hernychova L, Toman R et al (2005) Coxiella burnetii whole cell lysate protein identification by mass spectrometry and tandem mass spectrometry. Ann NY Acad Sci 1063:115–122
Skurnik M, Toivanen P (1993) Yersinia enterocolitica lipopolysaccharide: genetics and virulence. Trends Microbiol 1:148–152
Slaba K, Hussein A, Palkovic P et al (2003) Studies on immunological role of virenose and dihydrohydroxystreptose present in the Coxiella burnetii phase I lipopolysaccharide. Ann NY Acad Sci 990:505–509
Stoker MG, Fiset P (1956) Phase variation of the Nine Mile and other strains of Rickettsia burneti. Can J Microbiol 2:310–321
Stroeher UH, Jedani KE, Manning PA (1998) Genetic organization of the regions associated with surface polysaccharide synthesis in Vibrio cholerae O1, O139 and Vibrio anguillarum O1 and O2: a review. Gene 223:269–282
Svraka S, Toman R, Skultety L et al (2006) Establishment of a genotyping scheme for Coxiella burnetii. FEMS Microbiol Lett 254:268–274
Szkopinska A, Swiezewska E, Chojnacki T (1992) On the specificity of dolichol kinase and DolPMan synthase towards isoprenoid alcohols of different chain length in rat liver micro-somal membrane. Int J Biochem 24:1151–1157
Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17:1–14
Thompson HA, Hoover TA, Vodkin MH et al (2003) Do chromosomal deletions in the lipopolysaccharide biosynthetic regions explain all cases of phase variation in Coxiella burnetii strains? An update. Ann NY Acad Sci 990:664–670
Toman R (1991) Basic structural features of a lipopolysaccharide from the Coxiella burnetii strain Nine Mile in the virulent phase I. Acta Virol 35:224
Toman R, Kazar J (1991) Evidence for the structural heterogeneity of the polysaccharide component of Coxiella burnetii strain Nine Mile lipopolysaccharide. Acta Virol 35:531–537
Toman R, Skultety L (1994) Analysis of the 3-deoxy-D-manno-2-octulosonic acid region in a lipopolysaccharide isolated from Coxiella burnetii strain Nine Mile in phase II. Acta Virol 38:241–243
Toman R, Skultety L (1996) Structural study on a lipopolysaccharide from Coxiella burnetii strain Nine Mile in avirulent phase II. Carbohydr Res 283:175–185
Toman R, Skultety L, Kazar J (1993) On the determination of “Kdo-like substance” in the lipopolysaccharide from Coxiella burnetii strain Nine Mile in phase II. Acta Virol 37:196–198
Toman R, Skultety L, Ftacek P et al (1998) NMR study of virenose and dihydrohydroxystreptose isolated from Coxiella burnetii phase I lipopolysaccharide. Carbohydr Res 306:291–296
Toman R, Hussein A, Palkovic P et al (2003a) Structural properties of lipopolysaccharides from Coxiella burnetii strains Henzerling and S. Ann NY Acad Sci 990:563–567
Toman R, Hussein A, Slaba K et al (2003b) Further structural characteristics of the lipopolysaccharide from Coxiella burnetii strain Nine Mile in low virulent phase II. Acta Virol 47:129–130
Toman R, Garidel P, Andra J et al (2004) Physicochemical characterization of the endotoxins from Coxiella burnetii strain Priscilla in relation to their bioactivities. BMC Biochem 5:1 http://www.biomedcentral.com/1471-2091/5/1
Toman R, Skultety L, Ihnatko R (2009) Coxiella burnetii glycomics and proteomics – tools for linking structure to function. Ann NY Acad Sci 1166:67–78
Trefzer A, Salas JA, Bechthold A (1999) Genes and enzymes involved in deoxysugar biosynthesis in bacteria. Nat Prod Rep 16:283–299
Tujulin E, Lilliehook B, Macellaro A et al (1999) Early cytokine induction in mouse P388D1 macrophages infected by Coxiella burnetii. Vet Immunol Immunopathol 68:159–168
Ulmer AJ, Heine H, Feist W et al (1992) Biological activity of synthetic phosphono-oxyethyl analogues of lipid A and lipid A partial structures. Infect Immun 60:3309–3314
Vadovic P, Slaba K, Fodorova M et al (2005) Structural and functional characterization of the glycan antigens involved in immunobiology of Q fever. Ann NY Acad Sci 1063:149–153
Vadovic P, Fodorova M, Toman R (2007) Structural studies of lipid A of Piscirickettisa salmonis, the etiological agent of the salmonid rickettsial septicemia. Acta Virol 51:249–259
Vadovic P, Fuleova A, Ihnatko R et al (2009) Structural studies of lipid A from a lipopolysaccharide of the Coxiella burnetii isolate RSA 514 (Crazy). Clin Microbiol Infect 15:198–199
Van den Bosch L, Manning PA, Morona R (1997) Regulation of O-antigen chain length is required for Shigella flexneri virulence. Mol Microbiol 23:765–775
Van der Woude MW, Baumler AJ (2004) Phase and antigenic variation in bacteria. Clin Microbiol Rev 17:581–611
Vishwanath S, Hackstadt T (1988) Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii. Infect Immun 56:40–44
Vodkin MH, Williams JC (1986) Overlapping deletion in two spontaneous phase variants of Coxiella burnetii. J Gen Microbiol 132:2587–2594
Wang L, Jensen S, Hallman R et al (1998) Expression of the O antigen gene cluster is regulated by RfaH through the JUMPstart sequence. FEMS Microbiol Lett 165:201–206
Weiser JN, Love JM, Moxon ER (1989) The molecular mechanism of phase variation of Haemophilus influenzae lipopolysaccharide. Cell 59:657–665
Weisman LS, Ballou CE (1984) Biosynthesis of the mycobacterial methylmannose polysaccharide. Identification of a 3-O-methyltransferase. J Biol Chem 259:3464–3469
Weiss J, Hutzler M, Kao L (1986) Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil bactericidal/permeability-increasing protein. Infect Immun 51:594–599
Williams JC, Waag DM (1991) Antigens, virulence factors, and biological response modifiers of Coxiella burnetii: strategies for vaccine development. In: Williams JC, Thompson HA (eds) Q fever: the biology of Coxiella burnetii. CRC Press, Boca Raton, pp 175–222
Wollenweber HW, Schramek S, Moll H et al (1985) Nature and linkage of fatty acids present in lipopolysaccharides of phase I and phase II Coxiella burnetii. Arch Microbiol 142:6–11
Zamboni DS, Campos MA, Torrecilhas ACT et al (2004) Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection. J Biol Chem 279:54405–54415
Zhang G, Russell-Lodrigue KE, Andoh M et al (2007) Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice. J Immunol 179:8372–8380
Acknowledgement
This research was supported in part by the grant 2/0026/12 from the Scientific Grant Agency of Ministry of Education of Slovak Republic and the Slovak Academy of Sciences.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Narasaki, C.T., Toman, R. (2012). Lipopolysaccharide of Coxiella burnetii . In: Toman, R., Heinzen, R., Samuel, J., Mege, JL. (eds) Coxiella burnetii: Recent Advances and New Perspectives in Research of the Q Fever Bacterium. Advances in Experimental Medicine and Biology, vol 984. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4315-1_4
Download citation
DOI: https://doi.org/10.1007/978-94-007-4315-1_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4314-4
Online ISBN: 978-94-007-4315-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)